← Back to all earnings calls

Integrated Biopharma Inc Q4 FY2024 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2024 Q4 Call date: 2024-09-23 Concluded

Share

Quarter scorecard

Revenue (derived Q4)

$12.75M

-1.9% YoY

Gross margin (derived Q4)

10.1%

+2.5 pp YoY

Net income (derived Q4)

$268,000

+570% YoY

Documents & deck